The Chosun Ilbo on MSN
Ex-Samsung Researcher Develops Lung Health Device After Mother's Death
We are serializing ‘Peek into the Startup Notebook,’ which will serve as a model for those dreaming of starting a business ...
What if scientists could build a realistic model of the human lung, not full-sized, but grown in the lab from living cells? Why would they do this? VIDO scientists based at the University of ...
Researchers uncovered how lung cells decide whether to rebuild tissue or fight infection. This built-in “switch” may be the key to restoring the lungs’ natural repair ability. The discovery could lead ...
Kentucky has historically led the nation in lung cancer rates, but the statistics are turning around thanks to a decade-long ...
University of Delaware chemical engineer Catherine Fromen is developing ways to make drugs and therapies more effective for cancer patients. It’s work with real potential to improve human health. As a ...
The industry keeps echoing ideas from bleak satires and cyberpunk stories as if they were exciting possibilities, not grim ...
A seemingly outlandish method to deliver oxygen rectally – one of the winners of the 2024 “Ig Nobel” satirical science prize – may one day actually help lung disease patients, after achieving a key ...
Stephen has degrees in science (Physics major) and arts (English Literature and the History and Philosophy of Science), as well as a Graduate Diploma in Science Communication. Stephen has degrees in ...
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
GlobalData on MSN
RadNet acquires healthcare management solutions provider CIMAR UK
RadNet has announced the acquisition of cloud-native healthcare image management solutions provider CIMAR UK. The company ...
Unlock the power of Artificial Intelligence (AI) to drive impact and create value for your organisation. This data science for business course in London offers executives the practical tools, ...
CorriXR Therapeutics, Inc., an oncology-focused biotherapeutics company pioneering a novel gene editing platform to overcome drug resistance in solid tumors, today announced the publication of a ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果